REPRESENTATIVE OFFICE OF JANSSEN PHARMACEUTICALS NV TRADE DATA ANALYSIS
Access comprehensive trade data for Representative Office Of Janssen Pharmaceuticals Nv with ease. Explore trade shipments, top suppliers & buyers, and values without the hassle.
Representative Office Of Janssen Pharmaceuticals Nv – Overview
Eximpedia analyzes Representative Office Of Janssen Pharmaceuticals Nv export and import records, including data from 0 buyers and 2 suppliers. We provide an intelligence report of Representative Office Of Janssen Pharmaceuticals Nv that covers trade statistics, shipment values, quantities, exporters & importers and trade destinations
Representative Office Of Janssen Pharmaceuticals Nv Buyers, Suppliers & Shipments
Representative Office Of Janssen Pharmaceuticals Nv import markets
Explore the Representative Office Of Janssen Pharmaceuticals Nv import market with monthly import values, major importers, HS Codes, key ports, top suppliers, and competitors
TOP IMPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 3004390000 | 69.69 | 5 | 13.51 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004900000 | 18.83 | 11 | 29.73 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3006930000 | 8.33 | 11 | 29.73 |
| PHARMACEUTICAL GOODS SPECIFIED IN NOTE 4 TO THIS CHAPTER | |||
| 3002150000 | 0.25 | 7 | 18.92 |
| HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
| 3004320000 | 0.00 | 3 | 8.11 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
TOP IMPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| CANADA | 69.14 | 5 | 13.51 |
| UNITED STATES | 9.25 | 7 | 18.92 |
| ITALY | 7.43 | 2 | 5.41 |
| SWITZERLAND | 7.18 | 9 | 24.32 |
| FRANCE | 2.19 | 4 | 10.81 |
TOP IMPORT PORTS
| PORT NAME | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| UA209230 | 92.86 | 25 | 67.57 |
| UA100290 | 1.01 | 9 | 24.32 |
| UA100380 | 3.23 | 3 | 8.11 |
TOP IMPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| JV OPTIMA FARM LIMITED | 30.45 | 5786 |
| MERCK PHARMACEUTICAL ECZA AND KIMYA TIC A | 60.34 | 197 |
| ARES TRADING URUGUAY SA | 120.78 | 267 |
| REPRESENTATIVE OFFICE OF JANSSEN PHARMACEUTICALS NV | 139.38 | 37 |
| NOVO NORDISK HEALTH PRODUCTS TRADE LIMITED COMPANY | 234.11 | 2552 |
TOP IMPORT SUPPLIERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| PFIZER SERVICE COMPANY BV | 22.08 | 2884 |
| ELI LILLY EXPORT S A | 28.30 | 666 |
| ARES TRADING SA | 66.05 | 376 |
| JANSSEN PHARMACEUTICA NV | 139.07 | 4338 |
| NOVO NORDISK | 226.49 | 721 |
If you are looking to establish relationship with Representative Office Of Janssen Pharmaceuticals Nv Automation you can save time by getting access to the key decision makers and get a detailed report.
Representative Office Of Janssen Pharmaceuticals Nv Import Shipments
Discover the Representative Office Of Janssen Pharmaceuticals Nv with product description, import values, quantities, exporter name, country of origin and key destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 3006930000 | 1. MEDICINES FOR CLINICAL MEDICAL RESEARCH ACCORDING TO THE CNTO1959UCO3001 PROTOCOL: GUSELKUMAB 100MG OR PLACEBO 1 ML SOLUTION - 5 PACKS. REF/NUMBER: AAFM-12842. GUSELKUMAB 100MG OR PLACEBO 1 ML SOLUTION - 400 PACKS. REF/NUMBER: AAVX-12842. TERM SHELF LIFE UNTIL 14.07.2025. STORAGE CONDITIONS: FROM +02 GR.C TO +08 GR.C. MANUFACTURER CILAG AGTRADEMARK CILAG AG COUNTRY OF MANUFACTURE: CH |  |
|
SWITZERLAND | UKRAINE | 0 |
| 3006930000 | 1. MEDICINES FOR CLINICAL MEDICAL RESEARCH ACCORDING TO THE CNTO1959PSA3005 PROTOCOL: GUSELKUMAB 100 MG OR PLACEBO 1 ML SOLUTION - 140 PACKS. REF/NUMBER: AAPK-10498. EXPIRY DATE UNTIL 19.01.2025. STORAGE CONDITIONS: FROM +02 ░C TO +08 GR.S. MANUFACTURER CILAG AGTRADEMARK CILAG AG COUNTRY OF MANUFACTURE: CH | |
|
SWITZERLAND | UKRAINE | 0 |
| 3004900000 | 1. MEDICINES FOR CLINICAL MEDICAL RESEARCH ACCORDING TO PROTOCOL AC-055-315: MACITENTAN 10 MG / PLACEBO 36 FILM COATED TABLETS - 60 PACKS. REF/NUMBER: T341623. EXPIRY DATE UNTIL 22.11.2024. STORAGE CONDITIONS: FROM +15 GR.? UP TO +30 GR.S. MANUFACTURER PATHEON FRANCETRADE MARK PATHEON FRANCE COUNTRY OF MANUFACTURE: FR | |
|
FRANCE | UKRAINE | 0 |
| 3006930000 | 1. MEDICINES FOR CLINICAL MEDICAL RESEARCH ACCORDING TO PROTOCOL 73841937NSC3003: LAZERTINIB 80 MG PILLS OR PLACEBO NO. 93- 5 PCS. SERIES- T355863. MANUFACTURER / TRADEMARK: PATHEON PHARMACEUTICALS INC. COUNTRY OF MANUFACTURE: US. | |
|
UNITED STATES | UKRAINE | 0 |
| 3004900000 | 1. MEDICINES FOR CLINICAL MEDICAL RESEARCH ACCORDING TO PROTOCOL AC-055-315: MACITENTAN 10 MG / PLACEBO 36 FILM COATED TABLETS - 380 PACKS. REF/NUMBER: T356372. EXPIRY DATE UNTIL 04/24/2028. STORAGE CONDITIONS: FROM +15 GR.С UP TO +30 GR. S. MANUFACTURER PATHEON FRANCETRADE MARK PATHEON FRANCE COUNTRY OF MANUFACTURE: FR | |
|
FRANCE | UKRAINE | 0 |
| 3004900000 | 1. MEDICINES FOR CLINICAL MEDICAL RESEARCH ACCORDING TO PROTOCOL AC-055-315: MACITENTAN 75 MG / PLACEBO 36 FILM COATED TABLETS - 100 PACKS. REF/NUMBER: T347869. EXPIRY DATE UNTIL 20.06.2025. STORAGE CONDITIONS: FROM +15 GR.С UP TO +30 GR. S. MANUFACTURER EXCELLA GMBH & CO. KGTRADEMARK OF EXCELLA GMBH & CO. KG COUNTRY OF MANUFACTURE: DE | |
|
GERMANY | UKRAINE | 0 |
| 3006930000 | 1. DRUGS FOR CLINICAL MEDICAL RESEARCH UNDER PROTOCOL 67652000PCR3002: ABIRATERONE ACETATE 250 MG OR PLACEBO120 TABLETS - 175 PACK. REF/NUMBER: AATG-14276. EXPIRY DATE UNTIL 19.04.2025. STORAGE CONDITIONS: FROM +15 GR. C TO +30 GR .S.MANUFACTURER PATHEON INC.TRADEMARK PATHEON COUNTRY OF MANUFACTURE: CA | |
|
CANADA | UKRAINE | 0 |
| 3004900000 | 1. DRUGS, NOT IN AEROSOL PACKAGING, FOR CONDUCT OF CLINICAL MEDICAL STUDIES ACCORDING TO PROTOCOL 64091742PCR3001: NIRAPARIB 100MG, CAPSULES #72- 68 PACKAGE. SERIES- T347671. MANUFACTURER / TRADEMARK: QUOTIENT SCIENCES-PHILADELPHIA , LLC. COUNTRY OF MANUFACTURE: US | |
|
UNITED STATES | UKRAINE | 0 |
| 3004390000 | 1. DRUGS FOR CLINICAL MEDICAL TRIALS, RESEARCH PROTOCOL: 64091742PCR3001- ABIRATERONA ACETATE 250 MG., TABLETS #120- 80 PACK. MANUFACTURER / TRADEMARK: PATHEON INC. COUNTRY OF MANUFACTURE: SA | |
|
CANADA | UKRAINE | 0 |
| 3004320000 | 1. DRUGS FOR CLINICAL MEDICAL TRIALS, RESEARCH PROTOCOL: 64091742PCR3001- PREDNISONE 5MG., TABLETS #60- 40PACK. MANUFACTURER / TRADEMARK: MIBE GMBH ARZNEIMITTEL. COUNTRY OF MANUFACTURE: DE | |
|
GERMANY | UKRAINE | 0 |
| 3004900000 | 1. MEDICINES FOR CLINICAL MEDICAL RESEARCH ACCORDING TO PROTOCOL 64091742PCR3001; NIRAPARIB 100 MG NIRAPARIB CAPSULES 100 MG. - 75 PCS. REF. T340864, EXPIRATION DATE 04.10.2024 THE PRODUCT IS PLACED IN A PLASTIC THERMAL CONTAINER. MANUFACTURER-QUOTIENT SCIENCES- PHILADELPHIA, LLC, TRADEMARK-NO DATA; COUNTRY OF MANUFACTURE- US; | |
|
UNITED STATES | UKRAINE | 0 |
| 3006930000 | 1. DRUGS FOR CLINICAL MEDICAL RESEARCH UNDER PROTOCOL 73841937NSC3003: OSIMERTINIB 80MG CAPSULES OR PLACEBO #30- 15PCS. SERIES- T357964. MANUFACTURER / TRADEMARK : ASTRAZENECA AB. COUNTRY OF MANUFACTURE : SE | |
|
SWEDEN | UKRAINE | 0 |
| 3006930000 | 1. DRUGS FOR CLINICAL MEDICAL RESEARCH UNDER PROTOCOL 73841937NSC3003: LASERTINIB 80MG PILLS OR PLACEBO #93- 25PCS. SERIES- T359222. MANUFACTURER / TRADEMARK : PATHEON PHARMACEUTICALS INC. COUNTRY OF MANUFACTURE : US | |
|
UNITED STATES | UKRAINE | 0 |
| 3006930000 | 1. DRUGS FOR CLINICAL MEDICAL RESEARCH UNDER PROTOCOL 73841937NSC3003: OSIMERTINIB 80MG CAPSULES OR PLACEBO #30- 25PCS. SERIES- T357964. MANUFACTURER / TRADEMARK : ASTRAZENECA AB. COUNTRY OF MANUFACTURE : SE | |
|
SWEDEN | UKRAINE | 0 |
| 3004900000 | 1. MEDICINES FOR CLINICAL MEDICAL RESEARCH ACCORDING TO PROTOCOL 73841937NSC3003, NON-AEROSOL PACKAGING: JNJ-61186372 350MG(50MG/ML) 7ML SOLUTION/VIAL- 75 PCS. SERIES- T341137. MANUFACTURER / TRADEMARK: """"JANSEN SCIENCES IRELAND UC"""". COUNTRY OF MANUFACTURE : IE. """ | |
|
IRELAND | UKRAINE | 0 |
| 3004320000 | 1. MEDICINES FOR CLINICAL MEDICAL RESEARCH ACCORDING TO PROTOCOL 67652000PCR3002: PREDNISONE 5 MG 30 TABLETS - 25 PACKS. REF/NUMBER: ABMV-13698. EXPIRY DATE UNTIL 04/30/2026. STORAGE CONDITIONS: FROM +15 °C TO +30 °C .MANUFACTURER MIBE GMBH ARZNEIMITTELTRADEMARK MIBE GMBH ARZNEIMITTEL COUNTRY OF MANUFACTURE: DE | |
|
GERMANY | UKRAINE | 0 |
| 3004390000 | 1. MEDICINES FOR CLINICAL MEDICAL RESEARCH ACCORDING TO PROTOCOL 64091742PCR3001: ABIRATERONE ACETATE 250 MG 120 TABLETS FOR ORAL USE - 35 PACKS. REF/NUMBER: 4388126. EXPIRY DATE UNTIL 18.02.2025. STORAGE CONDITIONS: FROM +15 GR.C TO +30 GR .S.MANUFACTURER PATHEON INC.TRADEMARK PATHEON COUNTRY OF MANUFACTURE: CA | |
|
CANADA | UKRAINE | 0 |
| 3004390000 | 1. MEDICINES FOR CLINICAL MEDICAL RESEARCH ACCORDING TO PROTOCOL 67652000PCR3002:CJNJ67652000 (G010) 100/500 MG FDC ORPLACEBO 60 FILM COATED TABLETS - 70 PACKS. REF/NUMBER: AAUG-13698. EXPIRY DATE UNTIL 10.03.2025. CJNJ67652000 (G009) 50/ 500 MG FDC ORPLACEBO 60 FILM COATED TABLETS - 89 PACKS. REF/NUMBER: AAVJ-13698. EXPIRY DATE UNTIL 26.04.2025. STORAGE CONDITIONS: FROM +15 °C TO +30 °C. MANUFACTURER PATHEON FRANCETRADEMARK PATHEON FRANCE COUNTRY PRODUCTION: FR | |
|
FRANCE | UKRAINE | 0 |
| 3002150000 | 1. DRUGS FOR CLINICAL MEDICAL RESEARCH UNDER PROTOCOL 54767414MMY3030:DARATUMUMAB 400MG (20 MG/ML) 4 X 20 ML CONCENTRATE FOR SOLUTION - 6 PACK. REF/NUMBER: 4388185. EXPIRY DATE UNTIL 08.11.2024. STORAGE CONDITIONS: FROM +02 GR .C TO +08 GR.S. MANUFACTURER CILAG AG TRADEMARK CILAG AG COUNTRY OF PRODUCTION: CH | |
|
SWITZERLAND | UKRAINE | 0 |
| 3004900000 | 1. MEDICINES FOR CLINICAL MEDICAL RESEARCH ACCORDING TO PROTOCOL 67652000PCR3002: NIRAPARIB 100 MG OR PLACEBO 72 CAPSULES - 110 PACKS. REF/NUMBER: AAWE-13105. EXPIRY DATE UNTIL 04.10.2024. STORAGE CONDITIONS: FROM +15 GR.C TO +30 GR .S. MANUFACTURER QUOTIENT SCIENCESTRADEMARK QUOTIENT SCIENCES COUNTRY OF MANUFACTURE: US | |
|
UNITED STATES | UKRAINE | 0 |
Get Started with Eximpedia
Start 5 Days Free Trial
No Pay, No Delay - 5 days Your Way!
Book a Free Demo
Learn How our platform works in just 20 minutes!
Download Free Sample Report
Free Import-Export Sample data-One Click Away!
Why should you choose Eximpedia?
Broad Range of Country Datasets
Our dedicated team of experts delivers current and flexible data from key global locations, enabling you to make essential decisions with vital information and insights.
Easy to understand deep analysis
We use bespoke layered visualizations for diving deep into our country and logistics data to provide your team with graphical assistance and essential data analysis and reporting.
Most Accurate Information
All of our datasets are quality-controlled by layers of inspection before it ever reach your platform. This helps us maintain the high reliability our clients have come to trust.
Competitive Supplier Engagement Watch
Keep an eye out for any collaboration between your suppliers and your rivals, as this may impact their ability to satisfy your requirements.
Right away on-screen support
With instant remote on-screen assistance, chat support, and user training, our customer success team is available to you around the clock.
Access Database Across 130+ Countries
Explore competitors' shipment histories, statistical and analytical reports, and country-specific information from more than 130 nations.